Condition
Metformin Adverse Reaction
Total Trials
5
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
60%
3 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (1)
Early P 1 (1)
P 4 (3)
Trial Status
Completed4
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT04089280Not ApplicableCompleted
Probiotics in Metformin Intolerant Patients With Type 2 Diabetes
NCT03467763Phase 4CompletedPrimary
Trial of an Intervention to Improve Metformin Persistence and Adherence
NCT03445702Early Phase 1Completed
Metformin Gastrointestinal Intolerance: Measurement of Mitochondrial Complex I
NCT03980990Phase 4Unknown
Metformin Continuation Versus Interruption Following Coronary Angiography: a Pilot Randomized Controlled Trial
NCT03361878Phase 4Completed
Pharmacokinetics of Metformin Intolerance
Showing all 5 trials